{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Déchets industriels : Questions médicales les plus fréquentes",
"headline": "Déchets industriels : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Déchets industriels : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-02",
"dateModified": "2025-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Déchets industriels"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Déchets",
"url": "https://questionsmedicales.fr/mesh/D014866",
"about": {
"@type": "MedicalCondition",
"name": "Déchets",
"code": {
"@type": "MedicalCode",
"code": "D014866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.460.710"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Déchets industriels",
"alternateName": "Industrial Waste",
"code": {
"@type": "MedicalCode",
"code": "D007220",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Roman Fediuk",
"url": "https://questionsmedicales.fr/author/Roman%20Fediuk",
"affiliation": {
"@type": "Organization",
"name": "Polytechnic Institute, Far Eastern Federal University, 690922 Vladivostok, Russia."
}
},
{
"@type": "Person",
"name": "José Stênio Aragão Rebouças",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20St%C3%AAnio%20Arag%C3%A3o%20Rebou%C3%A7as",
"affiliation": {
"@type": "Organization",
"name": "Marine Station of Aquaculture, Institute of Oceanography, Federal University of Rio Grande, Rio Grande, Brazil."
}
},
{
"@type": "Person",
"name": "Fernando Pablo Silva Oliveira",
"url": "https://questionsmedicales.fr/author/Fernando%20Pablo%20Silva%20Oliveira",
"affiliation": {
"@type": "Organization",
"name": "Marine Station of Aquaculture, Institute of Oceanography, Federal University of Rio Grande, Rio Grande, Brazil."
}
},
{
"@type": "Person",
"name": "Alan Carvalho de Sousa Araujo",
"url": "https://questionsmedicales.fr/author/Alan%20Carvalho%20de%20Sousa%20Araujo",
"affiliation": {
"@type": "Organization",
"name": "Marine Station of Aquaculture, Institute of Oceanography, Federal University of Rio Grande, Rio Grande, Brazil."
}
},
{
"@type": "Person",
"name": "Helena Leão Gouveia",
"url": "https://questionsmedicales.fr/author/Helena%20Le%C3%A3o%20Gouveia",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Food Technology, School of Chemistry and Food, Federal University of Rio Grande, Rio Grande, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36268143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6833078"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35997934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12013-022-01089-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "A rapid fluorescent aptasensor for point-of-care detection of C-reactive protein.",
"datePublished": "2022-06-04",
"url": "https://questionsmedicales.fr/article/35714415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.talanta.2022.123661"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35821191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.",
"datePublished": "2022-06-24",
"url": "https://questionsmedicales.fr/article/35766701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1806-9282.20220236"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pollution de l'environnement",
"item": "https://questionsmedicales.fr/mesh/D004787"
},
{
"@type": "ListItem",
"position": 5,
"name": "Déchets",
"item": "https://questionsmedicales.fr/mesh/D014866"
},
{
"@type": "ListItem",
"position": 6,
"name": "Déchets industriels",
"item": "https://questionsmedicales.fr/mesh/D007220"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Déchets industriels - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Déchets industriels",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Déchets industriels",
"description": "Comment identifier les déchets industriels ?\nQuels tests pour analyser les déchets ?\nQuels indicateurs de dangerosité ?\nQui effectue le diagnostic des déchets ?\nQuels documents pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=C-Reactive+Protein&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Déchets industriels",
"description": "Quels symptômes d'exposition aux déchets ?\nComment les déchets affectent-ils la santé ?\nQuels effets à long terme ?\nY a-t-il des symptômes psychologiques ?\nQuels groupes sont les plus touchés ?",
"url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=C-Reactive+Protein&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Déchets industriels",
"description": "Comment prévenir l'exposition aux déchets ?\nQuelles formations pour les travailleurs ?\nComment réduire la production de déchets ?\nQuelles réglementations existent ?\nComment sensibiliser le public ?",
"url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=C-Reactive+Protein&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Déchets industriels",
"description": "Quel traitement pour l'exposition aiguë ?\nY a-t-il des antidotes pour les toxines ?\nComment traiter les irritations cutanées ?\nQuels soins pour les troubles respiratoires ?\nComment gérer les effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=C-Reactive+Protein&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Déchets industriels",
"description": "Quelles complications peuvent survenir ?\nY a-t-il des complications environnementales ?\nComment les déchets affectent-ils la biodiversité ?\nQuelles sont les conséquences économiques ?\nY a-t-il des impacts sur la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=C-Reactive+Protein&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Déchets industriels",
"description": "Quels sont les principaux facteurs de risque ?\nComment l'âge influence-t-il le risque ?\nY a-t-il des risques liés à la géographie ?\nQuels comportements augmentent le risque ?\nComment les conditions de travail influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007220?mesh_terms=C-Reactive+Protein&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les déchets industriels ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déchets industriels sont identifiés par leur origine, composition et propriétés dangereuses."
}
},
{
"@type": "Question",
"name": "Quels tests pour analyser les déchets ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests chimiques et biologiques sont effectués pour déterminer la toxicité et la composition."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de dangerosité ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indicateurs incluent la toxicité, la réactivité, la corrosivité et la pathogénicité."
}
},
{
"@type": "Question",
"name": "Qui effectue le diagnostic des déchets ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des experts en environnement et en gestion des déchets réalisent le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels documents pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fiches de données de sécurité et les rapports d'analyse sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'exposition aux déchets ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des irritations cutanées, des troubles respiratoires et des nausées."
}
},
{
"@type": "Question",
"name": "Comment les déchets affectent-ils la santé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent causer des maladies respiratoires, des cancers et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition prolongée peut entraîner des maladies chroniques et des troubles génétiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent survenir chez les personnes exposées."
}
},
{
"@type": "Question",
"name": "Quels groupes sont les plus touchés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs industriels et les communautés proches des sites de déchets sont les plus touchés."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux déchets ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles formations pour les travailleurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations sur la gestion des déchets et la sécurité au travail sont essentielles."
}
},
{
"@type": "Question",
"name": "Comment réduire la production de déchets ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter des pratiques de production durable et de recyclage pour minimiser les déchets."
}
},
{
"@type": "Question",
"name": "Quelles réglementations existent ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des lois encadrent la gestion des déchets industriels pour protéger la santé publique."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le public ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des ateliers peuvent sensibiliser sur les dangers des déchets."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'exposition aiguë ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'élimination de l'exposition et des soins médicaux d'urgence."
}
},
{
"@type": "Question",
"name": "Y a-t-il des antidotes pour les toxines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains cas nécessitent des antidotes spécifiques, selon la toxine impliquée."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irritations cutanées sont traitées par des crèmes apaisantes et des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Quels soins pour les troubles respiratoires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles respiratoires peuvent nécessiter des bronchodilatateurs et des corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements symptomatiques sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies chroniques, des cancers et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications environnementales ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la contamination des sols et des eaux peut avoir des effets durables sur l'écosystème."
}
},
{
"@type": "Question",
"name": "Comment les déchets affectent-ils la biodiversité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déchets peuvent nuire à la biodiversité en contaminant les habitats naturels."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences économiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les coûts de nettoyage et de santé publique peuvent peser lourdement sur l'économie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des impacts sur la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution et les risques sanitaires peuvent diminuer la qualité de vie des populations."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'exposition professionnelle et la proximité des sites pollués."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants et les personnes âgées sont plus vulnérables aux effets des déchets industriels."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la géographie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre près d'industries ou de décharges augmente le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements comme le non-respect des normes de sécurité augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment les conditions de travail influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conditions de travail précaires et non sécurisées augmentent le risque d'exposition."
}
}
]
}
]
}
The prognostic role of CRP (C-reactive protein) in gynecological tumors has been previously reported in individual studies, but whether CRP can be used as a separate potential prognostic factor has no...
A systematic search was carried out to find the literature evaluating the predictive role of CRP in the prognosis of gynecological cancer patients. For the purpose of determining the relationship betw...
A total of 19 studies, including 4062 patients, were analyzed retrospectively. The FIGO stage was related to the CRP level (OR = 0.43, 95% CI: 0.19-1.00). Age, lymph node metastasis, and histological ...
CRP may be utilized as a prognostic indicator for a variety of gynecologic malignancies, including cervical cancer, ovarian cancer, endometrial cancer, and vulvar cancer....
The acute phase C-reactive protein (CRP) is mainly synthesized and secreted by the liver in a cytokine-mediated response to infection or inflammation and circulates as a pentamer (pCRP) in plasma. Rec...
In this paper, we report on a novel fluorescent aptasensor based on aptamers modified by both nitrogen-doped graphene quantum dots (N-GQDs) and gold nanoparticles (AuNPs) for the detection of C-reacti...
To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), b...
ERS-RA was calculated in 1,251 "Cardiovascular Obesity and Rheumatic Disease Study (CORDIS)" database patients [(age 60.4(9.3) years; 78% female; disease duration, 11.6(8) years; CDAI, 9(9); CRP, 6.8(...
The mean (SD) 10-year risk of CV events was 12.9% (10). After adjusting for the use of DMARDs and biologics, CRP concentrations were significantly associated with 10-year risk of CV events (coefficien...
In a large cohort of RA patients without previous cardiovascular events, a 20 mg/L increase in CRP concentrations was associated with a 1% increase in 10-year risk of CV events. This suggests that act...
Chronic hepatitis C (CHC) is one of the most important health problems affecting the significant rate of world population and it may lead to cirrhosis and hepatocellular carcinoma. C-reactive protein ...
Patients with CHC infection who visited outpatient and inpatient internal medicine clinics of our institution between January 2021 and December 2021 were enrolled to this retrospective study. CLR of t...
Median CLR of CHC and control subjects was 2.61 (5.13%) and 0.31 (0.37%), respectively. CLR of the CHC group was significantly increased compared to the CLR of the controls (p<0.001). There was a sign...
Increased CLR in patients with CHC may be an alarming finding of liver fibrosis, as CLR is associated with both CHC and hepatic fibrosis....
Life's Essential 8 (LE8) is a score that includes modifiable risk factors for cardiovascular disease. Four health behaviors (diet, physical activity, nicotine exposure and sleep health) and four healt...
We investigate the interactions between C-reactive protein (CRP) and new CRP-binding peptide materials using experimental (biological and physicochemical) methods with the support of theoretical simul...
To assess whether low-grade inflammation, measured by serum high-sensitivity C-reactive protein (hsCRP) levels, is associated with...
A retrospective study....
University-affiliated IVF center....
In the present study, 875 women of normal weight who underwent their first fresh embryo transfer (ET) cycles for IVF treatment were divided into three groups according to serum concentrations of hsCRP...
Serum from women undergoing IVF was collected on days 2-4 of a spontaneous menstrual cycle prior to the commencement of ovarian stimulation....
The IVF outcomes included implantation, biochemical pregnancy, clinical pregnancy, miscarriage and live birth rates....
The women were divided into three groups according to the baseline serum levels of hsCRP as follows: low hsCRP (<1 mg/L; n=517), medium hsCRP (1-3 mg/L; n= 270), high hsCRP (>3 mg/L; n=88). The matern...
Among women of normal weight undergoing their first IVF treatment, it was found that low-grade inflammation was associated with reduced clinical pregnancy and live birth rates following fresh ET cycle...
Interest in using bedside C-reactive protein (CRP) and ferritin levels to identify patients with hyperinflammatory sepsis who might benefit from anti-inflammatory therapies has piqued with the COVID-1...
A prospective, observational cohort study....
Children with sepsis and organ failure in nine pediatric intensive care units in the United States....
Two hundred and fifty-five children were enrolled. Five distinct clinical multi-trajectory groups were identified. Plasma CRP (mg/dL), ferritin (ng/mL), and 31 cytokine levels were measured at two tim...
Group 1 had normal CRP and ferritin levels ( n = 8; 0% mortality); Group 2 had high CRP levels that became normal, with normal ferritin levels throughout ( n = 80; 5% mortality); Group 3 had high ferr...
Bedside CRP and ferritin levels can be used together to distinguish groups of children with sepsis who have different systemic inflammation cytokine responses and mortality risks. These data suggest f...
Social relationships are an important driver of health, and inflammation has been proposed as a key neurobiological mechanism to explain this effect. Behavioral researchers have focused on social rela...